Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02920346 · ClinicalTrials.gov registry record
Prospective Maternal Surveillance of SSA (Sjögren Syndrome A) Positive Pregnancies Using a Hand-held Fetal Heart Rate Monitor
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 700
- Enrollment target
NCT02920346 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 700 participants.
The verdict
NCT02920346 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 700 participants
- Enrollment target
Study Summary
The purpose of the research study "Heart Sounds at Home" is for pregnant SSA or SSA/SSB (Sjögren syndrome B) antibody positive mothers to use a Doppler fetal heart rate monitor to detect abnormal heart rates and rhythms in their babies before they are born.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2014-03 |
| Est. Completion | 2020-06-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02920346
The ClinicalTrials.gov registry entry for NCT02920346 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02920346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02920346 about?
NCT02920346 is a clinical study titled "Prospective Maternal Surveillance of SSA (Sjögren Syndrome A) Positive Pregnancies Using a Hand-held Fetal Heart Rate Monitor". The purpose of the research study "Heart Sounds at Home" is for pregnant SSA or SSA/SSB (Sjögren syndrome B) antibody positive mothers to use a Doppler fetal heart rate monitor to detect abnormal heart rates and rhythms in their babies before they are born.
What is the current status of trial NCT02920346?
This trial is currently completed. The enrollment target is 700 participants. The study started on 2014-03. Estimated completion is 2020-06-16.
Who is sponsoring clinical trial NCT02920346?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.